Adriatic
Argentina
Asia-Pacific
Australia and New Zealand
Bangladesh
Belgique (Belgium)
België (Belgium)
Brasil (Brazil)
Bulgaria
Canada
Canada
Česká republika (Czech Republic)
Chile
中国 (China)
Colombia
Costa Rica
Србија (Serbia)
Danmark (Denmark)
Deutschland (Germany)
Ecuador
España (Spain)
Europe
France
Ελλάδα (Greece)
香港特区 (Hong Kong SAR)
Indian Subcontinent
Ireland
Israel ישראל
Italia (Italy)
日本 (Japan)
Latinoamérica
Magyarország (Hungary)
México (Mexico)
Middle East and North Africa
Nederland (Netherlands)
Norge (Norway)
Österreich (Austria)
Panama
Portugal
Paraguay
Perú (Peru)
Polska (Poland)
Российская Федерация (Russia)
Puerto Rico
Romania
Schweiz (Switzerland)
Slovenská republika (Slovak Republic)
Southeast Asia
South Africa and Sub-Sahara
대한민국 (South Korea)
Suisse (Switzerland)
Suomi (Finland)
Sverige (Sweden)
台湾地区 (Taiwan)
Türkiye (Turkey)
United Kingdom
United States
Uruguay
Україна (Ukraine)
Press releases
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 28, 2016The MiniMed® 670G System Features the Company's Most Advanced SmartGuard(TM) Algorithm To-Date
DUBLIN - Sept. 28, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its MiniMed® 670G...
-
Sep 27, 2016Sugar.IQ with Watson Cognitive App to Preview at Health 2.0 Conference
DUBLIN and SANTA CLARA, Calif. - Sept. 27, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that Sugar.IQ with Watson, the first-of-its-kind cognitive app...
-
Sep 26, 2016The Company Continues to Pioneer Innovations in Deep Brain Stimulation and Surgical Technologies by Launching the Only Fully-Integrated Procedural Solution for Neurosurgery
DUBLIN and SAN DIEGO - September 26, 2016 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) clearance of StealthStation® Cranial Software as an aid for deep...
-
Sep 20, 2016New Clinical Data Presented in Complicated Type B Aortic Dissection at VIVA 2016
DUBLIN and LAS VEGAS - Sept. 20, 2016 - Medtronic plc (NYSE: MDT) today announced new data, demonstrating safety and efficacy at three years in acute complicated Type B aortic dissection patients...
-
Sep 19, 2016
DUBLIN and ORLANDO, Fla. - Sept. 19, 2016 - Medtronic plc (NYSE:MDT) announced the results of an analysis that reveals patients increasingly adhere to heart failure medications after they receive...
-
Sep 19, 2016Multiple, Rigorous Analyses Reinforce the Excellent Outcomes of IN.PACT Admiral Drug Coated Balloon and Differentiate it as Best-in-Class Treatment Option for PAD
DUBLIN and LAS VEGAS - September 19, 2016 - Medtronic today reinforced the superior durability, consistency, and safety of the IN.PACT Admiral drug-coated balloon (DCB) in patients with peripheral...
-
Sep 15, 2016
Dublin - September 15, 2016 - Medtronic (NYSE: MDT) today announced the appointment of Mark Ploof as Senior Vice President, Global Operations and Business Services effective October 31, 2016. He...
-
Sep 15, 2016
DUBLIN - September 15, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the publication of its Hybrid Closed Loop system pivotal trial results in the...
-
Sep 14, 2016Miniaturized Device Now Available for Use in Patients with Unexplained Syncope and Stroke
DUBLIN - Sept. 14, 2016 - Medtronic plc (NYSE: MDT) today announced it has received Ministry of Health, Labor and Welfare (MHLW) approval of the Reveal LINQ Insertable Cardiac Monitor (ICM) System...
-
Sep 13, 2016Medtronic Foundation Grants Support Organizations Committed
NORTHRIDGE, Calif. - Sept. 13, 2016 - Medtronic Foundation today announced that five community organizations will receive a combined $250,000 in Health Access Grants in recognition of their...
-
Sep 13, 2016IN.PACT Admiral DCB Indication Expansion to Treat Patients with ISR
DUBLIN - Sept. 13, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) approved the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) as a treatment...
-
Sep 12, 2016Clinical Practice Guidelines from European Society of Cardiology 2016 Reinforce Benefits of Cryoballoon Ablation and Long-Term Cardiac Monitoring
DUBLIN - September 12, 2016 - Two Medtronic plc (NYSE: MDT) innovations were acknowledged in updated guidelines published by the European Society of Cardiology (ESC): cryoballoon ablation for...
-
Sep 8, 2016Company named to the Dow Jones Sustainability North America Index (DJSI North America)
DUBLIN - September 8, 2016 - Medtronic plc (NYSE: MDT) was recognized today as one of the world's leading companies for sustainability with its ranking on the Dow Jones Sustainability North...
-
Sep 6, 2016
DUBLIN - Sept. 6, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services, and solutions, today announced that it will participate in the Morgan Stanley Global Healthcare...
-
Sep 1, 2016iPro2 Professional CGM with Enlite Provides Critical Link Between Glucose Variability and Lifestyle for Improved Diabetes Control
DUBLIN - Sept. 1, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the FDA approval of the Enlitesensor for use with iPro2 Professional Continuous Glucose...
-
Sep 1, 2016
DUBLIN - Sept. 1, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services, and solutions, today announced that it will participate in the Wells Fargo Global Healthcare...
-
Aug 29, 2016First-of-its-Kind Data on EffectivCRT(TM) for Heart Failure Patients with Atrial Fibrillation Presented at ESC
DUBLIN and ROME - Aug. 29, 2016 - Medtronic plc (NYSE:MDT) today announced results from the Cardiac Resynchronization Therapy Efficacy Enhancement (CRTee) study. The study showed that the...
-
Aug 28, 2016Results Featured at ESC 2016 Demonstrate Consistent, Sustained Safety and Effectiveness for the Medtronic Micra TPS
DUBLIN and ROME - AUGUST 28, 2016 - In the largest and longest clinical evaluation of leadless pacing patients to date, Medtronic plc (NYSE: MDT) today announced new long-term results from the...
-
Aug 26, 2016
DUBLIN - Aug. 26, 2016 - Medtronic plc (NYSE: MDT), on behalf of its indirect, wholly-owned subsidiary HeartWare International, Inc., today announced that, in connection with the completion of the...
-
Aug 25, 2016Revenue of $7.2 Billion Decreased 1% as Reported; Prior Year Had Extra Selling Week
DUBLIN - August 25, 2016 - Medtronic plc (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2017, which ended July 29, 2016. The company reported first quarter...
-
Aug 23, 2016Broadens Heart Failure Leadership Into Growing Circulatory Support Sector
DUBLIN - Aug. 23, 2016 - Medtronic plc (NYSE: MDT), the global leader in medical technology, has completed its acquisition of HeartWare International, Inc., a leading innovator of less-invasive,...
-
Aug 19, 2016
DUBLIN - August 19, 2016 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2017 second quarter cash dividend of $0.43 per ordinary share, representing a 13...
-
Aug 16, 2016
DUBLIN - Aug 16, 2016 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for the first quarter of fiscal year 2017, on Thursday, August 25, 2016. A news release will...
-
Aug 11, 2016
DUBLIN - August 11, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. commercial launch of its MiniMed 630G system with SmartGuard technology FDA...
-
Aug 8, 2016New Visual-Based Platform Helps Physicians Make Informed Programming Decisions by Providing an Intuitive Visualization of Patient-Specific Images and Data
DUBLIN - August 8, 2016 - Medtronic plc (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for SureTune2(TM) software, which provides patient-specific visualization to...
-
Aug 1, 2016Next-Generation Recapturable Device is the First-of-its-Kind Approved in Europe to Treat Intermediate Risk Patients as an Alternative to Open-Heart Surgery
DUBLIN - August 1, 2016 - Medtronic plc (NYSE: MDT) today announced CE (Conformité Européenne) mark for the self-expanding, recapturable and repositionable CoreValve(TM) Evolut(TM) R System to...
-
Jul 28, 2016New Service Integrates Medtronic Device Data with Remote Patient Monitoring Solutions
DUBLIN - June 28, 2016 - Medtronic plc (NYSE:MDT) today announced availability of its Beacon Heart Failure Management Service in the United States. This new service from Medtronic Care Management...
-
Jul 28, 2016- Global revenue increased approximately 25% from first quarter of 2016
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Jul 27, 2016VIVA Sponsored REALITY Study Assessing Vessel Preparation and Treatment in Severe Calcified Lesions Expands to Germany; Principal Investigators Named; First Patient Enrolled
DUBLIN and SAN JOSE, Calif. -July 27, 2016 - Medtronic plc (NYSE: MDT) and VIVA Physicians today report the first patient enrolled in the REALITY Study. The VIVA sponsored study is assessing...
-
Jul 25, 2016
DUBLIN and SHANGHAI - July 25, 2016 - Medtronic plc (NYSE: MDT) today announced the global launch of VariLoc Locking Compression Plate System in China and other select countries. With the...
-
Jul 20, 2016Clearance Gives Spine Surgeons a New Treatment Option for Spinal Tumor Patients
DUBLIN - July 20, 2016 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the CD Horizon® Fenestrated Screw Set, which can be used for...
-
Jul 19, 2016New Guardian(TM) Connect System Will Be Launched in Q2 FY17 Outside the U.S.
DUBLIN - July 19, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received CE (Conformité Européenne) Mark for its new Guardian(TM) Connect...
-
Jul 18, 2016Two-Level Use of Prestige LP Cervical Disc Exhibited Statistical Superiority in Overall Success at 24 Months Compared to Patients Treated with Two-Level Fusion
DUBLIN - July 18, 2016 - Medtronic plc (NYSE: MDT) announced today the U.S. Food and Drug Administration's (FDA) approval of the Prestige LP(TM) Cervical Disc for the treatment of cervical disc...
-
Jul 15, 2016Innovative Procedural Solutions Offer Efficiencies for Surgeons Using a Lateral Approach
DUBLIN - July 15, 2016 - Medtronic plc (NYSE: MDT) today announced the continued development of the OLIF Platform with the launch of the PivoxTM Oblique Lateral Spinal System with Lateral Plate...
-
Jul 15, 2016International Award Honors the Philanthropic Power of Patients; At Least 10 Honorees Will Each Receive a $20,000 Grant Donated to an Eligible Charity Organization of Their Choice
DUBLIN - July 15, 2016 - The Medtronic Foundation is seeking applications for the 2016 Bakken Invitation Award - an international program honoring and connecting people who have overcome health...
-
Jul 13, 2016Expanded Treatment Options for Patients with Longer SFA Lesions with Best-In-Class Drug-Coated Balloon Technology Now Available
DUBLIN - July 13, 2016 - Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) approval for the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) in longer, 150 mm...
-
Jul 11, 2016Clinical Study Conducted on Revision Subjects Support Expanded Indication for Patients with Previously Surgically Altered Tissue
DUBLIN - July 11, 2016 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) clearance of NuVent(TM), an EM sinus dilation system, for patients with scarred,...
-
Jun 27, 2016Extends Clinical and Commercial Leadership Into Growing Circulatory Support Sector
DUBLIN and FRAMINGHAM, Mass. - June 27, 2016 - Medtronic plc (NYSE: MDT), the global leader in medical technology, and HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of...
-
Jun 24, 2016
DUBLIN - June 24, 2016 - The board of directors of Medtronic plc (NYSE: MDT) today approved a 13 percent increase in its quarterly cash dividend, raising the quarterly amount to $0.43 per ordinary...
-
Jun 23, 2016
The World Stroke Organization (WSO) today announced a global partnership with Medtronic plc (NYSE:MDT) to increase stroke awareness through several initiatives. The two organizations will work...
-
Jun 18, 2016Medtronic Applied NASA Technology into Its Cardiac Devices
DUBLIN and COLORADO SPRINGS, COLO. - April 18, 2016 - The Space Foundation has inducted NASA Langley Research Center-Soluble Imide (LaRC-SI) - used in Medtronic plc (NYSE: MDT) leads connected to...
-
Jun 17, 2016Drug-Resistant Mesial Temporal Lobe Epilepsy Is the Focus of Medtronic's SLATE Study
DUBLIN - June 17, 2016 - Medtronic plc (NYSE: MDT) announced today the U.S. Food and Drug Administration's (FDA) approval of the Investigational Device Exemption (IDE) application for the pivotal...
-
Jun 10, 2016Secondary Analyses Presented at Cardiostim 2016 Highlight Positive, Real-World Patient Outcomes
DUBLIN AND NICE, FRANCE - June 10, 2016 - Medtronic plc (NYSE: MDT) today announced findings from the secondary analyses of the FIRE AND ICE clinical trial that demonstrate significantly fewer...
-
Jun 10, 2016CareLink® Portfolio Updates, IBM Watson Partnership Progress and New Strategic Alliances Delivering Intelligent Data and Actionable Information at ADA 2016
DUBLIN and NEW ORLEANS - June 10, 2016 - Delivering on its vision to transform care for the millions currently living with diabetes through intelligent data, Medtronic plc (NYSE:MDT) announced new...
-
Jun 9, 2016First Patient Treated with Medtronic Valiant TAAA Stent Graft System in Thoracoabdominal Aortic Aneurysm Study
DUBLIN and SIOUX FALLS, S.D. - February 9, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services and solutions and Sanford Health, one of the nation's largest health...
-
Jun 9, 2016Data Featured In Late-Breaking Trial Session at Cardiostim 2016 Show Micra TPS Safety Benefits Maintained Beyond Six Months
DUBLIN and NICE, FRANCE - JUNE 9, 2016 - Medtronic plc (NYSE:MDT) today announced new results from the Medtronic Micra® Transcatheter Pacing System (TPS) Global Clinical Trial in a late-breaking...
-
Jun 8, 2016Unique Next-Generation Device Evaluated in International Clinical Trial; First Procedure Performed at the University of Texas Health Science Center at Houston
DUBLIN and HOUSTON - June 8, 2016 - Medtronic plc (NYSE: MDT) and the University of Texas Health Science Center at Houston (UTHealth) today announced the first patient enrolled in a clinical study...
-
Jun 8, 2016Places ICD Leads Under Rib Cage, Outside Heart and Veins
DUBLIN and NICE, FRANCE - JUNE 8, 2016 - Medtronic plc (NSYE: MDT) today announced results from several feasibility studies evaluating a new approach to implantable cardioverter defibrillator...
-
Jun 7, 2016
DUBLIN - June 7, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its schedule of notable sessions that will be presented at the 76th Scientific Sessions...
-
Jun 6, 2016
DUBLIN and NEW YORK CITY - June 6, 2016 - Medtronic plc (NYSE: MDT), the global leader in medical technology, shared during its Investor Day today in New York City an overview of the company's...